|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/353 | (2006.01) |
| A61P 43/00 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/353 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Number of the document | 3482760 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17824314.3 |
| Date of filing the European patent application | 2017-07-06 | |
| (97) | Date of publication of the European application | 2019-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2017/024753 |
| Date | 2017-07-06 |
| (87) | Number | WO 2018/008711 |
| Date | 2018-01-11 |
| (30) | Number | Date | Country code |
| 201662359504 P | 2016-07-07 | US |
| (72) |
YOSHIDA, Takao , JP
SHOYAMA, Akiko , JP
TAKANO, Hirotsugu , JP
|
| (73) |
Ono Pharmaceutical Co., Ltd. ,
1-5, Doshomachi 2-chome
Chuo-ku, Osaka-shi, Osaka 541-8526,
JP
|
| (54) | COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR |
| COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR |